Literature DB >> 18762889

The interaction between ADAM22 and 14-3-3beta.

Pengcheng Zhu1, Yingying Sang, Rener Xu, Jing Zhao, Changben Li, Shouyuan Zhao.   

Abstract

ADAM family consists of a number of transmembrane proteins that contain a disintegrin and metalloprotease domain. ADAMs are involved in a highly diverse set of biological processes, including fertilization, neurogenesis, myogenesis and inflammatory response. The ADAM proteins have both cell adhesion and protease activities. Adam22 is highly expressed in human brain. The adam22-/- mice presented severe ataxia and died before weaning, but the function of ADAM22 is still unknown. 14-3-3 beta interacting with ADAM22 was detected by using yeast two-hybrid assay. The specificity of interaction between ADAM22 and 14-3-3beta was proved by in vitro binding assay and immunoprecipitation. The major 14-3-3beta binding site was located in the last 28 amino acid residues of ADAM22 cytoplasmic tail. Protein 14-3-3beta is abundant and plays an important role in mediating cell diffusion, migration and cell cycle control. The interaction of ADAM22 and 14-3-3beta suggests that the ADAM22 may play a crucial role in neural function and development.

Entities:  

Year:  2002        PMID: 18762889     DOI: 10.1007/BF02879745

Source DB:  PubMed          Journal:  Sci China C Life Sci        ISSN: 1006-9305


  2 in total

1.  PI3K p110α/Akt signaling negatively regulates secretion of the intestinal peptide neurotensin through interference of granule transport.

Authors:  Jing Li; Jun Song; Margaret G Cassidy; Piotr Rychahou; Marlene E Starr; Jianyu Liu; Xin Li; Garretson Epperly; Heidi L Weiss; Courtney M Townsend; Tianyan Gao; B Mark Evers
Journal:  Mol Endocrinol       Date:  2012-06-14

2.  ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis.

Authors:  Sara Charmsaz; Ben Doherty; Sinéad Cocchiglia; Damir Varešlija; Attilio Marino; Nicola Cosgrove; Ricardo Marques; Nolan Priedigkeit; Siobhan Purcell; Fiona Bane; Jarlath Bolger; Christopher Byrne; Philip J O'Halloran; Francesca Brett; Katherine Sheehan; Kieran Brennan; Ann M Hopkins; Stephen Keelan; Petra Jagust; Stephen Madden; Chiara Martinelli; Matteo Battaglini; Steffi Oesterreich; Adrian V Lee; Gianni Ciofani; Arnold D K Hill; Leonie S Young
Journal:  BMC Med       Date:  2020-11-19       Impact factor: 8.775

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.